MXPA05006382A - Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal. - Google Patents

Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.

Info

Publication number
MXPA05006382A
MXPA05006382A MXPA05006382A MXPA05006382A MXPA05006382A MX PA05006382 A MXPA05006382 A MX PA05006382A MX PA05006382 A MXPA05006382 A MX PA05006382A MX PA05006382 A MXPA05006382 A MX PA05006382A MX PA05006382 A MXPA05006382 A MX PA05006382A
Authority
MX
Mexico
Prior art keywords
colorectal cancer
methyltransferase
nicotinamide
marker
diagnosis
Prior art date
Application number
MXPA05006382A
Other languages
English (en)
Inventor
Zolg Werner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA05006382A publication Critical patent/MXPA05006382A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase

Abstract

La presente invencion se refiere al diagnostico de cancer colorrectal. Describe el uso de la proteina nicotinamida N-metiltransferasa (NNMT) en el diagnostico de cancer colorrectal. Se refiere a un metodo para el diagnostico de cancer colorrectal a partir de una muestra liquida, derivada de un individuo, al medir NNMT en la muestra. La medicion de NNMT puede, por ejemplo, usarse en la deteccion temprana o diagnostico de cancer colorrectal.
MXPA05006382A 2002-12-20 2003-12-19 Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal. MXPA05006382A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02028715 2002-12-20
PCT/EP2003/014583 WO2004057336A2 (en) 2002-12-20 2003-12-19 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer

Publications (1)

Publication Number Publication Date
MXPA05006382A true MXPA05006382A (es) 2005-10-24

Family

ID=32668733

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006382A MXPA05006382A (es) 2002-12-20 2003-12-19 Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.

Country Status (14)

Country Link
US (1) US7205118B2 (es)
EP (1) EP1579220B1 (es)
JP (1) JP4248496B2 (es)
KR (1) KR100711046B1 (es)
CN (1) CN100437115C (es)
AT (1) ATE370414T1 (es)
AU (1) AU2003296684A1 (es)
BR (1) BR0317394A (es)
CA (1) CA2510377C (es)
DE (1) DE60315715T2 (es)
ES (1) ES2291750T3 (es)
HK (1) HK1088947A1 (es)
MX (1) MXPA05006382A (es)
WO (1) WO2004057336A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE370414T1 (de) 2002-12-20 2007-09-15 Hoffmann La Roche Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
EP1761780A1 (en) * 2004-06-18 2007-03-14 Roche Diagnostics GmbH Use of inorganic pyrophosphatase as a marker for colorectal cancer
CN101088012A (zh) * 2004-12-23 2007-12-12 霍夫曼-拉罗奇有限公司 Asc作为结肠直肠癌的标记的用途
WO2006066916A1 (en) * 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Use of microsomal dipeptidase as a marker for colorectal cancer
WO2006066917A2 (en) * 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Use of asc as a marker for colorectal cancer
WO2007019875A1 (en) * 2005-08-19 2007-02-22 Indivumed Gmbh Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2007071367A1 (en) * 2005-12-22 2007-06-28 Roche Diagnostics Gmbh Use of a marker combination comprising osteopontin and carcinoembryonic antigen in the assessment of colorectal cancer
ES2345167T3 (es) * 2006-08-01 2010-09-16 F. Hoffmann-La Roche Ag Utilizacion de nnmt como marcador de cancer de pulmon.
US20110104177A1 (en) * 2006-12-28 2011-05-05 The Johns Hopkins University Histone deacetylase inhibitors, combination therapies and methods of use
KR100883530B1 (ko) 2007-07-30 2009-02-13 한국과학기술연구원 대장암 진단용 단백질 마커 아데노실호모시스테이나제 및이에 대한 항체를 포함하는 대장암 진단키트
KR101458483B1 (ko) * 2007-08-06 2014-11-10 제노마인(주) 신장암 진단 조성물 및 키트
ES2490613T3 (es) 2008-12-22 2014-09-04 F. Hoffmann-La Roche Ag ARMET como marcador de cáncer
US10815517B2 (en) 2009-04-28 2020-10-27 Roche Diagnostics Operations, Inc. Use of DPPIV/seprase as a marker for cancer
CA2760366A1 (en) 2009-05-29 2010-12-02 F.Hoffmann-La Roche Ag Secernin-1 as a marker for cancer
CA2767406A1 (en) 2009-07-16 2011-01-20 F. Hoffmann-La Roche Ag Flap endonuclease-1 as a marker for cancer
CN102375049A (zh) * 2010-08-04 2012-03-14 索尼公司 生物信息获取方法和烟酰胺代谢物测量方法
JP5976694B2 (ja) * 2011-03-11 2016-08-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 慢性閉塞性肺疾患（ｃｏｐｄ）のマーカーとしてのｎｎｍｔ
WO2015172249A1 (en) * 2014-05-13 2015-11-19 Vastcon Methionine aminopeptidase overexpression in the peripheral blood and peripheral blood mononuclear cells is a marker for colorectal cancer screening, diagnosis and prognosis
CN104894073B (zh) * 2015-02-16 2018-03-27 浙江大学 杂交瘤细胞株Zj/2D8及其检测尼克酰胺‑N‑甲基化酶抗原的应用
CN110308281B (zh) * 2019-06-06 2022-08-23 北京蛋白质组研究中心 一种泛素链固相检测方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547928A (en) 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
US5733748A (en) 1995-06-06 1998-03-31 Human Genome Sciences, Inc. Colon specific genes and proteins
US5939265A (en) * 1996-11-05 1999-08-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
JP2002523088A (ja) 1998-08-31 2002-07-30 バイエル コーポレイション 結腸癌において示差的に発現されるヒト遺伝子
US6936424B1 (en) 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
WO2001073027A2 (en) 2000-03-24 2001-10-04 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer
WO2001096388A2 (en) 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
CA2411278A1 (en) 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU2001266790A1 (en) 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
WO2002012280A2 (en) 2000-08-03 2002-02-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
CA2417866A1 (en) 2000-08-03 2002-02-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
JP2002070501A (ja) 2000-09-04 2002-03-08 Honda Motor Co Ltd 回転流体機械
AU2002306952A1 (en) 2001-03-28 2002-10-15 Matritech, Inc. Detection and treatment of colorectal cancer
WO2002090512A2 (en) * 2001-05-07 2002-11-14 Genaissance Pharmaceuticals, Inc. Haplotypes of the nnmt gene
ATE370414T1 (de) 2002-12-20 2007-09-15 Hoffmann La Roche Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs

Also Published As

Publication number Publication date
DE60315715D1 (de) 2007-09-27
HK1088947A1 (en) 2006-11-17
EP1579220B1 (en) 2007-08-15
EP1579220A2 (en) 2005-09-28
KR100711046B1 (ko) 2007-04-24
CN100437115C (zh) 2008-11-26
WO2004057336A3 (en) 2005-01-20
WO2004057336A2 (en) 2004-07-08
ATE370414T1 (de) 2007-09-15
CN1742204A (zh) 2006-03-01
KR20050114604A (ko) 2005-12-06
BR0317394A (pt) 2005-11-16
JP4248496B2 (ja) 2009-04-02
DE60315715T2 (de) 2008-06-05
US7205118B2 (en) 2007-04-17
AU2003296684A1 (en) 2004-07-14
US20060003368A1 (en) 2006-01-05
JP2006510889A (ja) 2006-03-30
ES2291750T3 (es) 2008-03-01
CA2510377A1 (en) 2004-07-08
CA2510377C (en) 2009-11-17

Similar Documents

Publication Publication Date Title
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
ATE554389T1 (de) Apex als marker für lungenkrebs
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2010000467A8 (en) Asc as a marker for lung cancer
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
CA2524708A1 (en) Use of protein cellular retinoic acid-binding protein ii (crabp ii) as marker for breast cancer
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
WO2005040807A3 (en) Swiprosin-2 as a breast cancer marker
WO2005124360A3 (en) Use of protein tebp as a marker for breast cancer
WO2005124354A3 (en) Use of protein ch10 as a marker for breast cancer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal